These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 15755257

  • 1. Blood haemoglobin is an independent predictor of B-type natriuretic peptide (BNP).
    Wold Knudsen C, Vik-Mo H, Omland T.
    Clin Sci (Lond); 2005 Jul; 109(1):69-74. PubMed ID: 15755257
    [Abstract] [Full Text] [Related]

  • 2. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
    Richards M, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, Frampton CM, Crozier IG, Yandle TG, Doughty R, MacMahon S, Sharpe N, Christchurch Cardioendocrine Research Group, Australia-New Zealand Heart Failure Group.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):52-60. PubMed ID: 16386664
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
    Omland T, Sabatine MS, Jablonski KA, Rice MM, Hsia J, Wergeland R, Landaas S, Rouleau JL, Domanski MJ, Hall C, Pfeffer MA, Braunwald E, PEACE Investigators.
    J Am Coll Cardiol; 2007 Jul 17; 50(3):205-14. PubMed ID: 17631211
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
    Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M, ADHERE Scientific Advisory Committee and Investigators.
    J Am Coll Cardiol; 2007 May 15; 49(19):1943-50. PubMed ID: 17498579
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C, Maria Sironi A, Favilli B, Poletti R, Prontera C, Ripoli A, Lombardi M, Emdin M.
    Int J Cardiol; 2005 Sep 15; 104(1):39-45. PubMed ID: 16137508
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
    Orn S, Manhenke C, Squire IB, Ng L, Anand I, Dickstein K.
    J Card Fail; 2007 Dec 15; 13(10):843-9. PubMed ID: 18068618
    [Abstract] [Full Text] [Related]

  • 11. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.
    Jourdain P, Jondeau G, Funck F, Gueffet P, Le Helloco A, Donal E, Aupetit JF, Aumont MC, Galinier M, Eicher JC, Cohen-Solal A, Juillière Y.
    J Am Coll Cardiol; 2007 Apr 24; 49(16):1733-9. PubMed ID: 17448376
    [Abstract] [Full Text] [Related]

  • 12. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy.
    Squire IB, Ørn S, Ng LL, Manhenke C, Shipley L, Aarsland T, Dickstein K.
    J Card Fail; 2005 Sep 24; 11(7):492-7. PubMed ID: 16198243
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Usefulness of B-type natriuretic peptide (BNP) for the diagnosis of new-onset heart failure with a preserved left ventricular systolic function in longstanding hypertensive patients with acute dyspnea].
    Arquès S, Roux E, Sbragia P, Pieri B, Gélisse R, Luccioni R, Ambrosi P.
    Arch Mal Coeur Vaiss; 2007 Feb 24; 100(2):113-20. PubMed ID: 17474496
    [Abstract] [Full Text] [Related]

  • 15. Elevated levels of brain natriuretic peptide as a predictor of impaired coronary endothelial function in patients with left ventricular remodeling.
    Ninomiya Y, Hamasaki S, Ishida S, Kataoka T, Saihara K, Okui H, Orihara K, Fukudome T, Shinsato T, Ichiki T, Mizoguchi E, Otsuji Y, Tei C.
    J Cardiol; 2006 Sep 24; 48(3):125-32. PubMed ID: 17007237
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-6 and tumor necrosis factor-alpha as biochemical markers of heart failure: a head-to-head clinical comparison with B-type natriuretic peptide.
    Boffa GM, Zaninotto M, Sartor R, Mion M, Berton A, Pasqualetto C, Razzolini R, Plebani M.
    J Cardiovasc Med (Hagerstown); 2009 Oct 24; 10(10):758-64. PubMed ID: 19553828
    [Abstract] [Full Text] [Related]

  • 17. B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis.
    Pimenta J, Paulo C, Gomes A, Silva S, Rocha-Gonçalves F, Bettencourt P.
    Liver Int; 2010 Aug 24; 30(7):1059-66. PubMed ID: 20492497
    [Abstract] [Full Text] [Related]

  • 18. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients.
    Post F, Weilemann LS, Messow CM, Sinning C, Münzel T.
    Crit Care Med; 2008 Nov 24; 36(11):3030-7. PubMed ID: 18824903
    [Abstract] [Full Text] [Related]

  • 19. Elevated B-type natriuretic peptide level: use with caution in patients with multiple co-morbidities and presenting with dyspnea.
    Jeevanantham V, Shrivastava R, Nannapaneni S, Khan A, Sengodan M, Nautiyal A, Navaneethan S, Hsi D.
    Indian Heart J; 2007 Nov 24; 59(1):64-8. PubMed ID: 19098338
    [Abstract] [Full Text] [Related]

  • 20. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock.
    Vergès B, Zeller M, Desgrès J, Dentan G, Laurent Y, Janin-Manificat L, L'Huillier I, Rioufol G, Beer JC, Makki H, Rochette L, Gambert P, Cottin Y.
    Eur Heart J; 2005 Sep 24; 26(17):1734-41. PubMed ID: 15831555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.